<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TPX</journal-id>
<journal-id journal-id-type="hwp">sptpx</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Pathol</journal-id>
<journal-title>Toxicologic Pathology</journal-title>
<issn pub-type="ppub">0192-6233</issn>
<issn pub-type="epub">1533-1601</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0192623312447551</article-id>
<article-id pub-id-type="publisher-id">10.1177_0192623312447551</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Regular Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitogen-activated Protein Kinase Phosphatase (Mkp)-1 Protects Mice against Acetaminophen-induced Hepatic Injury</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wancket</surname>
<given-names>Lyn M.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0192623312447551">1</xref>
<xref ref-type="aff" rid="aff2-0192623312447551">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meng</surname>
<given-names>Xiaomei</given-names>
</name>
<xref ref-type="aff" rid="aff2-0192623312447551">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rogers</surname>
<given-names>Lynette K.</given-names>
</name>
<xref ref-type="aff" rid="aff2-0192623312447551">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Yusen</given-names>
</name>
<xref ref-type="aff" rid="aff1-0192623312447551">1</xref>
<xref ref-type="aff" rid="aff2-0192623312447551">2</xref>
<xref ref-type="corresp" rid="corresp1-0192623312447551"/>
</contrib>
</contrib-group>
<aff id="aff1-0192623312447551">
<label>1</label>Department of Veterinary Bioscience, The Ohio State University College of Veterinary Medicine, Columbus, Ohio, USA</aff>
<aff id="aff2-0192623312447551">
<label>2</label>Department of Pediatrics, Center for Perinatal Research, The Research Institute at Nationwide Children’s Hospital, The Ohio State University College of Medicine, Columbus, Ohio, USA</aff>
<author-notes>
<corresp id="corresp1-0192623312447551">Yusen Liu, Department of Pediatrics, Center for Perinatal Research, The Research Institute at Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, USA; e-mail: <email>yusen.liu@nationwidechildrens.org</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2012</year>
</pub-date>
<volume>40</volume>
<issue>8</issue>
<fpage>1095</fpage>
<lpage>1105</lpage>
<permissions>
<copyright-statement>© 2012 by The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society of Toxicologic Pathology</copyright-holder>
</permissions>
<abstract>
<p>c-Jun N-terminal kinase (JNK) activation promotes hepatocyte death during acetaminophen overdose, a common cause of drug-induced liver failure.  While mitogen-activated protein kinase (MAPK) phosphatase (Mkp)-1 is a critical negative regulator of JNK MAPK, little is known about the role of Mkp-1 during hepatotoxicity. In this study, we evaluated the role of Mkp-1 during acute acetaminophen toxicity. <italic>Mkp-1<sup>+/+</sup></italic> and <italic>Mkp-1<sup>−/−</sup></italic> mice were dosed ip with vehicle or acetaminophen at 300 mg/kg (for mechanistic studies) or 400 mg/kg (for survival studies). Tissues were collected 1–6 hr post 300 mg/kg dosing to assess glutathione levels, organ damage, and MAPK activation. <italic>Mkp-1<sup>−/−</sup></italic> mice exhibited more rapid plasma clearance of acetaminophen than did <italic>Mkp-1<sup>+/+</sup></italic> mice, indicated by a quicker decline of plasma acetaminophen level. Moreover, <italic>Mkp-1<sup>−/−</sup></italic> mice suffered more severe liver injury, indicated by higher plasma alanine transaminase activity and more extensive centrilobular apoptosis and necrosis. Hepatic JNK activity in <italic>Mkp-1<sup>−/−</sup></italic> mice was higher than in <italic>Mkp-1<sup>+/+</sup></italic> mice. Finally, <italic>Mkp-1<sup>−/−</sup></italic> mice displayed a lower overall survival rate and shorter median survival time after dosing with 400 mg/kg acetaminophen. The more severe phenotype exhibited by <italic>Mkp-1<sup>−/−</sup> </italic>mice indicates that Mkp-1 plays a protective role during acute acetaminophen overdose, potentially through regulation of JNK.</p>
</abstract>
<kwd-group>
<kwd>toxicity</kwd>
<kwd>hepatic</kwd>
<kwd>mouse</kwd>
<kwd>acetaminophen</kwd>
<kwd>Mkp-1</kwd>
<kwd>JNK</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0192623312447551">
<title>Introduction</title>
<p>The analgesic acetaminophen is currently the most frequent cause of drug-induced hepatic failure in the United States, with intentional and unintended overdose contributing to 10,000 to 50,000 hospitalizations and 500 deaths annually (Nourjah et al. <xref ref-type="bibr" rid="bibr42-0192623312447551">2006</xref>). The mechanism mediating acetaminophen toxicity is well characterized as a consequence of saturation of metabolism (Mitchell et al. <xref ref-type="bibr" rid="bibr38-0192623312447551">1973a</xref>; Nelson <xref ref-type="bibr" rid="bibr41-0192623312447551">1990</xref>). Under prescribed dosing, the majority of acetaminophen is rapidly metabolized in the liver by phase II glucuronide and sulfate conjugation enzymes to nontoxic compounds (Mitchell et al. <xref ref-type="bibr" rid="bibr38-0192623312447551">1973a</xref>). Additionally, a relatively minor portion of the drug is converted by phase I cytochrome p450 enzymes to the highly reactive intermediate metabolite N-acetyl-<italic>p</italic>-benzoquinone-imine (NAPQI; Dahlin et al. <xref ref-type="bibr" rid="bibr12-0192623312447551">1984</xref>; Gonzalez and Kimura <xref ref-type="bibr" rid="bibr18-0192623312447551">2003</xref>). NAPQI has an extremely short half-life and is rapidly excreted after conjugation with glutathione under normal physiological conditions (Mitchell et al. <xref ref-type="bibr" rid="bibr39-0192623312447551">1973b</xref>). Acetaminophen overdose overwhelms the major metabolic pathway of acetaminophen elimination, causing both increased NAPQI formation and depletion of the reduced form of cellular glutathione (Mitchell et al. <xref ref-type="bibr" rid="bibr39-0192623312447551">1973b</xref>). Excess NAPQI can covalently bind to essential cellular macromolecules, causing hepatocyte death and liver injury (Jollow et al. <xref ref-type="bibr" rid="bibr27-0192623312447551">1974</xref>; Jollow et al. <xref ref-type="bibr" rid="bibr26-0192623312447551">1973</xref>; Mitchell et al. <xref ref-type="bibr" rid="bibr39-0192623312447551">1973b</xref>). Recently, specific downstream biochemical signaling cascades have been identified that perpetuate acetaminophen-induced hepatotoxicity (reviewed in Han et al. <xref ref-type="bibr" rid="bibr21-0192623312447551">2010</xref>), including the JNK family (Gunawan et al. <xref ref-type="bibr" rid="bibr19-0192623312447551">2006</xref>; Latchoumycandane et al., <xref ref-type="bibr" rid="bibr32-0192623312447551">2007</xref>; Henderson et al. <xref ref-type="bibr" rid="bibr23-0192623312447551">2007</xref>).</p>
<p>JNK proteins are members of the MAPK family that regulate numerous hepatic cellular processes and diseases, including hepatocyte apoptosis and development of steatohepatitis in mouse models (Qiao et al. <xref ref-type="bibr" rid="bibr45-0192623312447551">2003</xref>; Singh et al. <xref ref-type="bibr" rid="bibr54-0192623312447551">2009</xref>). During acetaminophen overdose, JNK is activated, likely by the upstream kinases, including apoptosis signal-regulating kinase 1 (Nakagawa et al. <xref ref-type="bibr" rid="bibr40-0192623312447551">2008</xref>). Activated JNK perpetuates hepatic damage by altering redox status (Nakagawa et al. <xref ref-type="bibr" rid="bibr40-0192623312447551">2008</xref>), modulating bcl-2 family activity (Gunawan et al. <xref ref-type="bibr" rid="bibr19-0192623312447551">2006</xref>; Latchoumycandane et al. <xref ref-type="bibr" rid="bibr32-0192623312447551">2007</xref>), and altering mitochondrial biogenesis (Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>). Inhibition of JNK reduces hepatic injury by preventing mitochondrial stress and reducing peroxynitrate formation (Saito et al. <xref ref-type="bibr" rid="bibr50-0192623312447551">2010</xref>). Both JNK1 and JNK2 isoforms are expressed in the liver (Bogoyevitch <xref ref-type="bibr" rid="bibr5-0192623312447551">2006</xref>) and blocking the activation of both isoforms simultaneously protects mice against acetaminophen-induced hepatotoxicity (Gunawan et al. <xref ref-type="bibr" rid="bibr19-0192623312447551">2006</xref>; Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>). Since JNK is emerging as a key mediator in acetaminophen-induced liver injury, recent studies have examined endogenous or exogenous JNK-inhibitors for potential therapeutic use (Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>; Saito et al. <xref ref-type="bibr" rid="bibr50-0192623312447551">2010</xref>). One such class of inhibitors is the MkP subfamily of the dual specificity protein phosphatase (DUSP) family. </p>
<p>In mammalian cells, MkPs are the primary phosphatases responsible for dephosphorylating MAPKs (Keyse <xref ref-type="bibr" rid="bibr28-0192623312447551">2000</xref>). MkPs are upregulated by many of the same extracellular stimuli that activate MAPKs, including mitogens and stress (Chi et al. <xref ref-type="bibr" rid="bibr10-0192623312447551">2006</xref>; Salojin et al., <xref ref-type="bibr" rid="bibr51-0192623312447551">2006</xref>; <xref ref-type="bibr" rid="bibr65-0192623312447551">Zhao et al., 2006</xref>, <xref ref-type="bibr" rid="bibr33-0192623312447551">Lau and Nathans 1985</xref>; Wang and Liu <xref ref-type="bibr" rid="bibr60-0192623312447551">2007</xref>). MkP-1, also referred to as DUSP1, is the prototypical member of the MkP family and it preferentially inactivates the stress-induced MAPKs JNK and p38 in most tissues (Liu et al. <xref ref-type="bibr" rid="bibr36-0192623312447551">1995</xref>; Raingeaud et al. <xref ref-type="bibr" rid="bibr46-0192623312447551">1995</xref>; Franklin and Kraft, <xref ref-type="bibr" rid="bibr15-0192623312447551">1997</xref>; Franklin et al., <xref ref-type="bibr" rid="bibr16-0192623312447551">1998</xref>; Chi et al., <xref ref-type="bibr" rid="bibr10-0192623312447551">2006</xref>; Hammer et al., <xref ref-type="bibr" rid="bibr20-0192623312447551">2006</xref>; <xref ref-type="bibr" rid="bibr65-0192623312447551">Zhao et al. 2006</xref>). While Mkp-1 is dispensable for development, growth, and maturation (Dorfman et al. <xref ref-type="bibr" rid="bibr13-0192623312447551">1996</xref>), loss of Mkp-1 prolongs JNK and p38 activation and enhances host susceptibility to systemic inflammatory challenges such as endotoxemia and bacterial infections (Chi et al. <xref ref-type="bibr" rid="bibr10-0192623312447551">2006</xref>; Frazier et al. <xref ref-type="bibr" rid="bibr17-0192623312447551">2009</xref>; Hammer et al. <xref ref-type="bibr" rid="bibr20-0192623312447551">2006</xref>; Wang et al. <xref ref-type="bibr" rid="bibr61-0192623312447551">2007</xref>; <xref ref-type="bibr" rid="bibr65-0192623312447551">Zhao et al. 2006</xref>). While MkP-1 is expressed in human and rodent hepatocytes (Tomasi et al. <xref ref-type="bibr" rid="bibr58-0192623312447551">2010</xref>) and inhibition of MkP-1 prolongs JNK activation (Boutros et al. <xref ref-type="bibr" rid="bibr7-0192623312447551">2008</xref>), relatively little is known about the role of Mkp-1 during toxic hepatic injuries. The goal of this study was to examine the effects of Mkp-1 deficiency in a mouse model of acute acetaminophen overdose. Our data support a role for Mkp-1 in protection against acute acetaminophen-induced hepatic toxicity, likely through inhibiting JNK activity.</p>
</sec>
<sec id="section2-0192623312447551" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-0192623312447551">
<title>Experimental Animals</title>
<p><italic>Mkp-1<sup>−/−</sup></italic> mice were originally generated from embryos provided by Bristol-Myers Squibb Pharmaceutical Research Institute and the creation of these mice has been described previously (Dorfman et al. <xref ref-type="bibr" rid="bibr13-0192623312447551">1996</xref>). Male <italic>Mkp-1<sup>+/+</sup>
</italic> and <italic>Mkp-1<sup>−/−</sup></italic> mice 8–16 weeks of age on a C57/129 mixed background were used for all experiments. All mice were housed at 25°C in a vivarium with humidity between 30% and 70%, with a 12-hr alternating light–dark cycle. All experiments were performed according to National Institutes of Health guidelines and the experimental protocols were approved by the Institutional Animal Care and Use Committee at the Research Institute at Nationwide Children’s Hospital.</p>
</sec>
<sec id="section4-0192623312447551">
<title>Acetaminophen Overdose</title>
<p>In all experiments, <italic>Mkp-1<sup>+/+</sup></italic> and <italic>Mkp-1<sup>−/−</sup></italic> mice were fasted for 16–18 hr to deplete glutathione stores prior to acetaminophen dosing, as has been performed previously (Hirayama et al. <xref ref-type="bibr" rid="bibr25-0192623312447551">1983</xref>). Mice then received a single ip injection of vehicle (phosphate buffered saline), 300, or 400 mg/kg acetaminophen (Sigma). These doses are within the hepatotoxic ranges reported previously for mouse strains such as C57BL/6 (Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>) and ICR (Rogers et al. <xref ref-type="bibr" rid="bibr48-0192623312447551">2000</xref>). The 300 mg/kg dose was selected to model a severe but nonfatal overdose, while the 400 mg/kg dose was selected as a potentially lethal dose for use in a survival study. Mice receiving vehicle or 300 mg/kg acetaminophen were euthanized by overdose of pentobarbital 1, 2, 4, or 6 hr after dosing, and blood and liver were collected for further analyses. To evaluate the effect of Mkp-1 deficiency on survival, mice received a 400 mg/kg ip injection of acetaminophen, were re-fed standard chow 6 hr post drug administration (to allow for multiday monitoring), and observed through 120 hr to calculate overall survival.</p>
</sec>
<sec id="section5-0192623312447551">
<title>Biochemical Plasma Measurements</title>
<p>Plasma alanine transaminase (ALT) activity was determined using a Thermo Scientific assay reagent (Infinity ALT(GPT) Liquid Stable Reagent) as previously described (Bergmeyer, Scheibe, and Wahlefeld <xref ref-type="bibr" rid="bibr2-0192623312447551">1978</xref>; Henry et al. <xref ref-type="bibr" rid="bibr24-0192623312447551">1960</xref>). Briefly, this assay measures the ALT-mediated conversion of alanine to pyruvate. Pyruvate is reduced to lactate by lactate dehydrogenase with the simultaneous oxidation of NADH to NAD, which is monitored by measuring the rate of decrease in absorbance at 340 nm. IL-6 concentration in plasma was determined using an ELISA kit (BD Biosciences).</p>
<p>Acetaminophen levels were measured in mouse plasma by high-performance liquid chromatography (HPLC) with UV detection at 248 nm using a modification of the method previously described (<xref ref-type="bibr" rid="bibr8-0192623312447551">Buckpitt et al. 1977</xref>; <xref ref-type="bibr" rid="bibr57-0192623312447551">To and Wells 1985</xref>). Briefly, 20 µL of plasma was mixed with 25 µL ice-cold acetonitrile and placed on ice for 10 min. The sample was then centrifuged at 10,000 rpm for 5 min at 4°C. The supernatant was collected and the pellet was washed with 25 µL ice-cold acetonitrile and centrifuged again. The supernatants were pooled, dried under a stream of nitrogen gas, and reconstituted in 100 µL of mobile phase A. Analysis was carried out on a Shimadzu HPLC (Shimadzu Scientific Instruments, Columbia, MD) equipped with a Zorbax SB-C18 3.0 × 150 mm (5 µm) column (Agilent Technologies, Santa Clara, CA). Acetaminophen was separated using a solvent gradient at room temperature with a flow rate of 0.6 mL/min. Initial conditions were 95% mobile phase A (0.1% acetic acid in water with 2% methanol) and 5% mobile phase B (0.1% acetic acid in methanol with 2% water). After a 3-min hold, mobile phase B was increased to 20% over 12 min using a solvent curve of −8 (convex) and held at 20% for 5 min. The column was then washed with 80% mobile phase B and reequilibrated with starting conditions. Acetaminophen concentrations were calculated by experimentally derived standard curves.</p>
</sec>
<sec id="section6-0192623312447551">
<title>Histopathology</title>
<p>Liver samples were fixed in formalin, routinely processed into paraffin blocks, and cut into 4-µm sections. The sections were stained with H&amp;E for histological analysis. The evaluator scored the slides while blinded to the genotype, treatment group, and time point. Lesion scores were assigned as follows (adapted from Blazka et al. <xref ref-type="bibr" rid="bibr4-0192623312447551">1996</xref>): grade 0 (no evidence of histological lesions), 1 (minimal congestion and mild hepatocellular cytoplasmic degeneration immediately adjacent to the central vein), 2 (moderate congestion and degeneration with individual necrotic hepatocytes in the periportal region), 3 (marked congestion and degeneration with necrotic hepatocytes extending into the midzonal regions), and 4 (severe congestion and degeneration and necrosis that bridges between most centrilobular zones). TUNEL staining was performed following the manufacturer’s instructions using an In Situ Cell Death Detection Kit (Roche), and counterstained with hemotoxylin. Slides were scored by selecting ten 400× fields that were centered on a centrilobular vein and counting the number of TUNEL-positive nuclei in each field.</p>
</sec>
<sec id="section7-0192623312447551">
<title>Total Hepatic Glutathione Levels</title>
<p>Hepatic levels of reduced glutathione (GSH) and oxidized glutathione (GSSG) were measured as previously described (Rogers et al. <xref ref-type="bibr" rid="bibr48-0192623312447551">2000</xref>). Briefly, frozen tissues were placed into buffer at a ratio of 10% (tissue weight/volume of buffer). Tissue homogenates were prepared in 0.1 M phosphate buffer (pH 7.4) containing ethylenediaminetetraacetic acid (EDTA) either supplemented with 0.01 M <italic>N</italic>-ethylmaleimide (for assessing GSSG) or without <italic>N</italic>-ethylmaleimide (for assessing GSH). Tissue contents of both GSH and GSSG were measured by the enzyme recycling method as previously described (Adams, Lauterburg, and Mitchell <xref ref-type="bibr" rid="bibr1-0192623312447551">1983</xref>).</p>
</sec>
<sec id="section8-0192623312447551">
<title>Western Blot Analysis</title>
<p>Western blot analysis was performed as previously described (Chen et al. <xref ref-type="bibr" rid="bibr9-0192623312447551">2002</xref>), using liver homogenates. Rabbit polyclonal antibodies against p-JNK (Cell Signaling Technology), p-p38 (Cell Signaling Technology), JNK1 (Santa Cruz Biotechnology), and p38 (Santa Cruz Biotechnology) were used. Immunoreactivity was visualized using an enhanced chemiluminescent (ECL plus) detection kit (GE Healthcare Life Sciences). Scanned radiographic films were analyzed for band intensity using ImageQuant (GE Healthcare Life Sciences) to determine densitometry values.</p>
</sec>
<sec id="section9-0192623312447551">
<title>Statistical Analysis</title>
<p>Differences in plasma IL-6, plasma ALT, plasma acetaminophen levels, hepatic GSH and GSSG concentrations, and densitometry measurements between groups were compared using a <italic>t</italic>-test. Survival differences between <italic>Mkp-1<sup>+/+</sup></italic> and <italic>Mkp-1<sup>−/−</sup></italic> mice were assessed by Kaplan-Meier curve analysis with a log-rank test. Prism statistics software (GraphPad Software) was used for all analyses and a value of <italic>p</italic> &lt; .05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="section10-0192623312447551">
<title>Results</title>
<sec id="section11-0192623312447551">
<title>Plasma ALT, IL-6, and Acetaminophen Levels</title>
<p>To determine whether <italic>Mkp-1<sup>−/−</sup></italic> mice exhibit higher levels of biomarkers of liver damage and inflammation, plasma levels of ALT and the acute inflammatory cytokine IL-6 were measured in <italic>Mkp-1<sup>+/+</sup></italic> and <italic>Mkp-1<sup>−/−</sup></italic> mice treated with 300 mg/kg acetaminophen. While ALT levels were comparable between the two strains at 1 hr post dosing, <italic>Mkp-1<sup>−/−</sup></italic> mice had significantly higher ALT levels by 4 hr posttreatment, which continued to trend higher at 6 hr (<xref ref-type="fig" rid="fig1-0192623312447551">Fig. 1A</xref>). Additionally, while plasma levels of IL-6 were below detectable levels in <italic>Mkp-1<sup>+/+</sup></italic> mice at all time points, plasma levels of IL-6 were detectable in the <italic>Mkp-1<sup>−/−</sup></italic> at 4 hr and remained elevated through 6 hr post dosing (<xref ref-type="fig" rid="fig1-0192623312447551">Fig. 1B</xref>). Finally, acetaminophen levels were measured in both strains after dosing with PBS or acetaminophen for 2, 4, or 6 h. <italic>Mkp-1<sup>−/−</sup></italic> mice demonstrated a more rapid clearance of acetaminophen from the plasma, with significantly lower plasma levels at 4 and 6 hr post dosing (<xref ref-type="fig" rid="fig1-0192623312447551">Fig. 1C</xref>).</p>
<fig id="fig1-0192623312447551" position="float">
<label>Figure 1</label>
<caption>
<p>Loss of Mkp-1 function elevates systemic markers of liver damage and inflammation and increases plasma clearance of acetaminophen. Mice were fasted, treated with vehicle or 300 mg/kg acetaminophen ip, and euthanized at the indicated time points. Plasma levels of ALT (A), IL-6 (B), and acetaminophen (C) were measured. Values represent mean ± standard error (<italic>n</italic> = 3–8 mice per group). *<italic>p</italic> &lt; .05.</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig1.tif"/>
</fig>
</sec>
<sec id="section12-0192623312447551">
<title>Histopathology and TUNEL Staining</title>
<p>There were no appreciable histopathological lesions in <italic>Mkp-1<sup>+/+</sup></italic> (<xref ref-type="fig" rid="fig2-0192623312447551">Fig. 2A</xref>) or <italic>Mkp-1<sup>−/−</sup></italic> (<xref ref-type="fig" rid="fig2-0192623312447551">Fig. 2B</xref>) mice treated with vehicle. Likewise, no histopathological abnormality was seen in either <italic>Mkp-1<sup>+/+</sup></italic> (<xref ref-type="fig" rid="fig2-0192623312447551">Fig. 2C</xref>) or <italic>Mkp-1<sup>−/−</sup></italic> (<xref ref-type="fig" rid="fig2-0192623312447551">Fig. 2D</xref>) mice treated with 300 mg/kg acetaminophen for 2 hr. At 4 hr post dosing, sections from <italic>Mkp-1<sup>+/+</sup></italic> mice generally lacked histopathological lesions and were similar to the vehicle-treated groups (<xref ref-type="fig" rid="fig2-0192623312447551">Fig. 2E</xref>). In contrast, at 4 hr post dosing, livers from <italic>Mkp-1<sup>−/−</sup></italic> showed evidence of cytoplasmic degeneration, including marked vacuolation of centrilobular hepatocytes, centrilobular congestion, and scattered necrotic hepatocytes (<xref ref-type="fig" rid="fig2-0192623312447551">Fig. 2F</xref>). By 6 hr post acetaminophen dosing, <italic>Mkp-1<sup>−/−</sup></italic> livers displayed widespread congestion, hepatocellular vacuolation, and necrosis of centrilobular hepatocytes, with lesions extending into the midzonal regions (<xref ref-type="fig" rid="fig2-0192623312447551">Figs. 2H</xref> and <xref ref-type="fig" rid="fig3-0192623312447551">3B</xref>). In contrast, lesions in <italic>Mkp-1<sup>+/+</sup></italic> mice at 6 hr post dosing were limited to mild degenerative changes such as hepatocellular vacuolation and mild congestion, with rare necrotic cells (<xref ref-type="fig" rid="fig2-0192623312447551">Figs. 2G</xref> and <xref ref-type="fig" rid="fig3-0192623312447551">3A</xref>). When comparing lesion grades, livers from <italic>Mkp-1<sup>−/−</sup></italic> mice had higher mean degeneration scores than livers from <italic>Mkp-1<sup>+/+</sup></italic> mice at both 4 and 6 hr post acetaminophen dosing (<xref ref-type="fig" rid="fig3-0192623312447551">Fig. 3C</xref>).</p>
<fig id="fig2-0192623312447551" position="float">
<label>Figure 2</label>
<caption>
<p>Enhanced centrilobular congestion, hepatocellular degeneration, and necrosis in acetaminophen-treated <italic>Mkp-1<sup>−/−</sup></italic> mice. Mice were fasted and then treated with vehicle (A, B) or 300 mg/kg acetaminophen ip for 2 (C, D), 4, (E, F), or 6 (G, H) hr. Representative photomicrographs from <italic>Mkp-1<sup>+/+</sup></italic> mice are (A, C, E, and G); sections from <italic>Mkp-1<sup>−/−</sup></italic> mice are (B, D, F, and H; 40×).</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig2.tif"/>
</fig>
<fig id="fig3-0192623312447551" position="float">
<label>Figure 3</label>
<caption>
<p>Enhanced centrilobular congestion, hepatocellular degeneration, necrosis, and histological grade in <italic>Mkp-1<sup>−/−</sup></italic> mice at 6 hr post acetaminophen treatment. Mice were fasted and then treated with 300 mg/kg acetaminophen ip for 6 hr. (A) Representative photomicrograph of liver from a <italic>Mkp-1<sup>+/+</sup></italic> mouse showing mild degeneration and occasional necrotic hepatocytes (400×). (B) Representative photomicrograph of liver from a<italic> Mkp-1<sup>−/−</sup></italic> mouse showing diffuse centrilobular hepatic necrosis, indicated by loss of nuclei and dissolution of nuclear membranes (arrow) (400×). (C) Group scores for hepatocellular degeneration/necrosis in centrilobular regions of liver sections. Values represent mean ± standard error from three mice.</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig3.tif"/>
</fig>
<p>In addition to increased centrilobular necrosis, livers from <italic>Mkp-1<sup>−/−</sup></italic> mice underwent widespread centrilobular apoptosis at earlier time points. TUNEL-positive nuclei were absent in mice treated with PBS or acetaminophen for 2 hr. By 4 hr posttreatment, TUNEL-positive nuclei remained rare in <italic>Mkp-1<sup>+/+</sup></italic> livers (<xref ref-type="fig" rid="fig4-0192623312447551">Fig. 4A</xref> and C), while <italic>Mkp-1<sup>−/−</sup></italic> livers had numerous TUNEL-positive nuclei surrounding central veins and foci of necrotic cell debris (<xref ref-type="fig" rid="fig4-0192623312447551">Fig. 4B</xref> and C). The number of TUNEL-positive nuclei at 4 hr was significantly higher in <italic>Mkp-1<sup>−/−</sup></italic> livers (<xref ref-type="fig" rid="fig4-0192623312447551">Fig. 4E</xref>). By 6 hr, TUNEL-positive nuclei were common in <italic>Mkp-1<sup>+/+</sup></italic> livers, while centrilobular cells in <italic>Mkp-1<sup>−/−</sup></italic> livers included large numbers of both TUNEL-positive and necrotic cells.</p>
<fig id="fig4-0192623312447551" position="float">
<label>Figure 4</label>
<caption>
<p>Enhanced centrilobular apoptosis in <italic>Mkp-1<sup>−/−</sup>
</italic> mice at 4 hr post acetaminophen treatment. Mice were fasted and then treated with vehicle or 300 mg/kg acetaminophen ip for the time points indicated. Representative photomicrographs of liver sections from <italic>Mkp-1<sup>+/+</sup></italic> mice (A and C) and <italic>Mkp-1<sup>−/−</sup></italic> mice (B and D) with TUNEL staining to identify apoptotic nuclei (dark brown staining).   A and B are 100× and C and D are 400×. (C) Number of positive nuclei in ten, 400× fields. Values represent mean ± standard error from three mice.</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig4.tif"/>
</fig>
</sec>
<sec id="section13-0192623312447551">
<title>Hepatic Glutathione</title>
<p>While the hepatic levels of both GSH and GSSG trended slightly higher in vehicle-treated <italic>Mkp-1<sup>−/−</sup>
</italic> mice compared to wild-type liver samples, acetaminophen treatment rapidly depleted hepatic GSH and GSSG in both genotypes (<xref ref-type="fig" rid="fig5-0192623312447551">Fig. 5A</xref> and B). The hepatic GSH and GSSG levels did not substantially recover during the 6-hr post dosing interval in either wild-type or <italic>Mkp-1<sup>−/−</sup>
</italic> mice, indicating prolonged glutathione depletion in this model.</p>
<fig id="fig5-0192623312447551" position="float">
<label>Figure 5</label>
<caption>
<p>Acetaminophen reduces hepatic GSH and GSSG levels to a comparable degree in wild-type and knockout animals. Liver GSH (A) and GSSG (B) levels were determined for fasted <italic>Mkp-1<sup>+/+</sup>
</italic> and <italic>Mkp-1<sup>−/−</sup>
</italic> mice dosed with vehicle or 300 mg/kg acetaminophen and sacrificed at the time points indicated. Values represent mean ± standard error (<italic>n</italic> = 3–8 mice/group).</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig5.tif"/>
</fig>
</sec>
<sec id="section14-0192623312447551">
<title>Western Blot</title>
<p>Since previous studies have demonstrated that JNK activation is a key event that perpetuates hepatocellular damage during acetaminophen overdose (Gunawan et al. <xref ref-type="bibr" rid="bibr19-0192623312447551">2006</xref>; Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>; Nakagawa et al. <xref ref-type="bibr" rid="bibr40-0192623312447551">2008</xref>; Saito et al. <xref ref-type="bibr" rid="bibr50-0192623312447551">2010</xref>), we assessed JNK activity in liver homogenates from <italic>Mkp-1<sup>+/+</sup>
</italic> and <italic>Mkp-1<sup>−/−</sup>
</italic> mice treated with vehicle or 300 mg/kg acetaminophen. Phospho-JNK1 and phospho-JNK2 levels were very low in livers from vehicle-treated wild-type and <italic>Mkp-1</italic> knockout mice. In <italic>Mkp-1<sup>+/+</sup>
</italic> mice, acetaminophen dosing resulted in JNK activation within 2 hr that plateaued by 4 hr (<xref ref-type="fig" rid="fig6-0192623312447551">Fig. 6A</xref>, top panel).  In contrast, JNK1 and JNK2 activity in <italic>Mkp-1<sup>−/−</sup>
</italic> livers continued to increase between 2 and 6 hr. Quantitation of the levels of phosphorylated JNK indicates that at 6 hr, levels of both phospho-JNK1 and phospho-JNK2 were significantly higher in the livers of <italic>Mkp-1<sup>−/−</sup>
</italic> mice than in livers of wild-type mice (<xref ref-type="fig" rid="fig6-0192623312447551">Fig. 6B</xref>). In contrast to phospho-JNK, the level of another stress-induced Mkp-1 substrate, phospho-p38, was only moderately increased over the time course examined (<xref ref-type="fig" rid="fig5-0192623312447551">Fig. 5A</xref> bottom panel). The only time point where p38 activity was significantly different between the two genotypes was at 2 hr (<xref ref-type="fig" rid="fig6-0192623312447551">Fig. 6C</xref>), which occurred prior to the development of elevated plasma ALT levels and histopathological lesions in <italic>Mkp-1<sup>−/−</sup>
</italic> mice.</p>
<fig id="fig6-0192623312447551" position="float">
<label>Figure 6.</label>
<caption>
<p>Loss of Mkp-1 function prolongs hepatic JNK MAPK activation. Liver homogenates were prepared from fasted <italic>Mkp-1<sup>+/+</sup>
</italic> and <italic>Mkp-1<sup>−/−</sup>
</italic> mice treated with vehicle or 300 mg/kg acetaminophen and euthanized at the time points indicated. Homogenates were probed with antibodies against p-JNK, JNK1, p-p38, and p38. (A) Scans of representative Western blot radiographs. (B) Densitometry histograms of scans for p-JNK1 and p-JNK2 in part (A) normalized to JNK1. (C) Densitometry histograms of scans for p-p38 in part (A) normalized to total p38. Values represent mean ± standard error from three mice; <italic>n</italic> = 3–5 mice/group over all blots performed. *<italic>p</italic> &lt; .05.</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig6.tif"/>
</fig>
</sec>
<sec id="section15-0192623312447551">
<title>Survival</title>
<p>To assess survival, fasted <italic>Mkp-1<sup>+/+</sup>
</italic> (<italic>n</italic> = 34) and <italic>Mkp-1<sup>−/−</sup>
</italic> (<italic>n</italic> = 28) mice were administered a single high dose of acetaminophen (400 mg/kg), re-fed 6 hr later, and monitored through 120 hr (<xref ref-type="fig" rid="fig7-0192623312447551">Fig. 7</xref>). <italic>Mkp-1<sup>−/−</sup>
</italic> mice displayed significantly decreased overall survival (32%) compared to <italic>Mkp-1<sup>+/+</sup>
</italic> mice (43%). Additionally, wild-type mice displayed a longer median survival time of 71 hr, compared to a median survival time of only 23 hr in <italic>Mkp-1<sup>−/−</sup>
</italic> mice.</p>
<fig id="fig7-0192623312447551" position="float">
<label>Figure 7.</label>
<caption>
<p>Mkp-1 promotes survival during high dose acetaminophen toxicity. Fasted <italic>Mkp-1<sup>+/+</sup>
</italic> and <italic>Mkp-1<sup>−/−</sup>
</italic> mice were treated with 400 mg/kg acetaminophen, re-fed 6 hr later, and survival monitored through 120 hr. <italic>n</italic> = 34 <italic>Mkp-1<sup>+/+</sup>
</italic>; 28 <italic>Mkp-1<sup>−/−</sup>
</italic>. *<italic>p</italic> &lt; .05.</p>
</caption>
<graphic xlink:href="10.1177_0192623312447551-fig7.tif"/>
</fig>
</sec>
</sec>
<sec id="section16-0192623312447551">
<title>Discussion</title>
<p>This current study evaluated the role of Mkp-1 in mice exposed to a single hepatotoxic or lethal dose of acetaminophen. We found that <italic>Mkp-1<sup>−/−</sup>
</italic> mice displayed biochemical and histological evidence of more severe hepatocellular injury and systemic inflammation compared to wild-type animals. The enhanced hepatocellular damage in <italic>Mkp-1<sup>−/−</sup>
</italic> mice correlated with prolonged hepatic JNK activation. Finally, <italic>Mkp-1<sup>−/−</sup>
</italic> mice had a lower overall survival rate and a shorter mean survival time compared to wild-type mice. </p>
<p>Elevations in ALT are characteristic of acute acetaminophen overdose (Larson et al. <xref ref-type="bibr" rid="bibr31-0192623312447551">2005</xref>; Ostapowicz et al. <xref ref-type="bibr" rid="bibr43-0192623312447551">2002</xref>), with mean ALT values in human patients generally &gt; 4,000 IU/L, which is markedly higher than typical ALT levels in other drug or viral-induced causes of hepatic failure. The high plasma ALT levels in <italic>Mkp-1<sup>−/−</sup>
</italic> mice (<xref ref-type="fig" rid="fig1-0192623312447551">Fig. 1A</xref>) closely parallel the levels previously reported in mouse models (Blazka et al. <xref ref-type="bibr" rid="bibr4-0192623312447551">1996</xref>; Rogers et al. <xref ref-type="bibr" rid="bibr48-0192623312447551">2000</xref>).   In addition to markers of direct hepatocellular damage, acetaminophen-induced cell injury often leads to activation of MAPKs and subsequent release of pro-inflammatory cytokines, such as IL-6 (Connolly et al. <xref ref-type="bibr" rid="bibr11-0192623312447551">2011</xref>). IL-6 (<xref ref-type="fig" rid="fig1-0192623312447551">Fig. 1B</xref>) is a pro-inflammatory cytokine known to be upregulated in <italic>Mkp-1<sup>−/−</sup>
</italic> mice in response to other injurious stimuli, such as lipopolysaccharide (LPS) (Chi et al. <xref ref-type="bibr" rid="bibr10-0192623312447551">2006</xref>; Salojin et al. <xref ref-type="bibr" rid="bibr51-0192623312447551">2006</xref>; <xref ref-type="bibr" rid="bibr65-0192623312447551">Zhao et al. 2006</xref>) and <italic>Staphylococcus aureus</italic> (Wang et al. <xref ref-type="bibr" rid="bibr61-0192623312447551">2007</xref>). In response to hepatic toxins such as acetaminophen, IL-6 levels can be rapidly released by resident hepatic cells, including Kupffer and dendritic cells (Connolly et al. <xref ref-type="bibr" rid="bibr11-0192623312447551">2011</xref>; Lacour et al. <xref ref-type="bibr" rid="bibr30-0192623312447551">2005</xref>). IL-6 can also serve as a prognostic biomarker for decreased survival in human acute liver failure (Berry et al. <xref ref-type="bibr" rid="bibr3-0192623312447551">2010</xref>) and is a potential downstream mediator of acetaminophen-induced hepatic injury in mice (Bourdi et al. <xref ref-type="bibr" rid="bibr6-0192623312447551">2007</xref>). While we did not directly examine other pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α or interleukin (IL)-1β, it is likely that those would also be elevated in acetaminophen-treated <italic>Mkp-1<sup>−/−</sup>
</italic> mice. Upregulation of TNF-α and IL-1β often parallels higher IL-6 release in <italic>Mkp-1<sup>−/−</sup>
</italic> mice treated with bacterial ligands (Chi et al. <xref ref-type="bibr" rid="bibr10-0192623312447551">2006</xref>; Salojin et al. <xref ref-type="bibr" rid="bibr51-0192623312447551">2006</xref>; Zhao et al. <xref ref-type="bibr" rid="bibr65-0192623312447551">2006</xref>).</p>
<p>The finding that <italic>Mkp<sup>−/−</sup>
</italic> mice more rapidly cleared plasma levels of acetaminophen in this model was a novel finding (<xref ref-type="fig" rid="fig1-0192623312447551">Fig. 1C</xref>). Previous studies have demonstrated interactions and even modulation of cytochrome P450 activity by JNK (Liu et al. <xref ref-type="bibr" rid="bibr34-0192623312447551">2002a</xref>; Liu et al. <xref ref-type="bibr" rid="bibr35-0192623312447551">2002b</xref>;, Yasunami et al., <xref ref-type="bibr" rid="bibr64-0192623312447551">2004</xref>, Tang, Pettersson, and Norlin <xref ref-type="bibr" rid="bibr56-0192623312447551">2008</xref>; Wang et al. <xref ref-type="bibr" rid="bibr62-0192623312447551">2010</xref>). Although we did not directly investigate the mechanism that led to the increased plasma clearance at 4 and 6 hr post dosing, we postulate that the elevated JNK levels due to Mkp-1 deficiency in the <italic>Mkp-1<sup>−/−</sup>
</italic> mice might speed up the metabolism in general, and could enhance cytochrome P450 activity and thus increase the metabolism of acetaminophen to reactive metabolites. Indeed, it has been shown that, compared to wild-type mice, <italic>Mkp-1<sup>−/−</sup>
</italic> mice have higher JNK-mediated metabolic activity rate in certain pathways (Wu et al. <xref ref-type="bibr" rid="bibr63-0192623312447551">2006</xref>). The increased production of cytochrome P450 metabolites could cause a more rapid depletion of glutathione and more rapid alkylation of other protein thiols, thus enhancing toxicity.    </p>
<p>The centrilobular congestion and necrosis seen in the livers of both genotypes (but more severe in <italic>Mkp-1<sup>−/−</sup>
</italic>
 animals; <xref ref-type="fig" rid="fig2-0192623312447551">Figs. 2</xref> and <xref ref-type="fig" rid="fig3-0192623312447551">3</xref>) is the pattern commonly reported both in animal models (Blazka et al. <xref ref-type="bibr" rid="bibr4-0192623312447551">1996</xref>; Placke et al. <xref ref-type="bibr" rid="bibr44-0192623312447551">1987</xref>) and in human cases of acetaminophen toxicity (Ramachandran and Kakar <xref ref-type="bibr" rid="bibr47-0192623312447551">2009</xref>; Walker, Racz, and McElligott <xref ref-type="bibr" rid="bibr59-0192623312447551">1983</xref>, Mitchell et al., <xref ref-type="bibr" rid="bibr39-0192623312447551">1973b</xref>, Ostapowicz et al., <xref ref-type="bibr" rid="bibr43-0192623312447551">2002</xref>). Localized tissue hypoxia is one of the contributing factors leading to necrosis and initial loss of centrilobular hepatocytes. Hypoxia is known to enhance activation of JNK in the liver (McCloskey et al. <xref ref-type="bibr" rid="bibr37-0192623312447551">2004</xref>) and was recently shown to upregulate Mkp-1 expression in a model of ischemia and reperfusion (Boutros et al. <xref ref-type="bibr" rid="bibr7-0192623312447551">2008</xref>), suggesting that MkP-1 may play a role in the hepatic response to the stress of decreased oxygen tension. Apoptotic cell death is now recognized as a component of hepatic acetaminophen toxicity, and the results of the TUNEL-staining indicate a more rapid onset of centrilobular apoptosis in <italic>Mkp-1<sup>−/−</sup>
</italic> mice (<xref ref-type="fig" rid="fig4-0192623312447551">Fig 4</xref>). MAPK play a key role in mediating the apoptotic response, and it is probable that prolonged activation of MAPK such as JNK may lead to the more rapid onset of apoptosis in the <italic>Mkp-1<sup>−/−</sup>
</italic> mice.</p>
<p>There were no significant differences in GSH or GSSG levels in wild-type and knockout mice during acetaminophen overdose (<xref ref-type="fig" rid="fig5-0192623312447551">Fig. 5</xref>), indicating that the enhanced hepatotoxicity and decreased survival in <italic>Mkp-1<sup>−/−</sup>
</italic> animals was not due to altered depletion of glutathione. As was seen in our model, acetaminophen treatment can rapidly exhaust cytoplasmic and mitochondrial GSH stores (Hirayama et al. <xref ref-type="bibr" rid="bibr25-0192623312447551">1983</xref>) concurrent with GSSG depletion. This depletion of both GSH and GSSG likely occurs secondary to the formation of thioether metabolites of NAPQI bound to GSH, thereby preventing the normal shunting of GSH to GSSG (Adams, Lauterburg, and Mitchell <xref ref-type="bibr" rid="bibr1-0192623312447551">1983</xref>; Nelson <xref ref-type="bibr" rid="bibr41-0192623312447551">1990</xref>). </p>
<p>JNK1 and JNK2 activation were prolonged in Mkp-1 deficient livers in our model (<xref ref-type="fig" rid="fig6-0192623312447551">Fig. 6A</xref>, B), correlating with enhanced hepatic injury in <italic>Mkp-1<sup>−/−</sup>
</italic> mice. Activation of hepatic JNK is recognized as a key event in the progression and exacerbation of acetaminophen toxicity, and inhibition of both JNK1 and JNK2 has been shown to protect mice against acetaminophen-induced hepatotoxicity (Gunawan et al. <xref ref-type="bibr" rid="bibr19-0192623312447551">2006</xref>; Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>). Our results are consistent with other models in which <italic>Mkp-1<sup>−/−</sup>
</italic> mice display prolonged JNK and p38 activation during systemic diseases such as endotoxemia and bacterial infection (Chi et al. <xref ref-type="bibr" rid="bibr10-0192623312447551">2006</xref>;Hammer et al. <xref ref-type="bibr" rid="bibr20-0192623312447551">2006</xref>; Zhao et al., <xref ref-type="bibr" rid="bibr65-0192623312447551">2006</xref>; Frazier et al., <xref ref-type="bibr" rid="bibr17-0192623312447551">2009</xref>; Wang et al. <xref ref-type="bibr" rid="bibr61-0192623312447551">2007</xref>). While p38 activation has not been identified as contributing to hepatic damage in acetaminophen overdose (Nakagawa et al. <xref ref-type="bibr" rid="bibr40-0192623312447551">2008</xref>) and p38 activity was only mildly elevated at 2 hr in Mkp-1 deficient mice (<xref ref-type="fig" rid="fig6-0192623312447551">Fig. 6C</xref>), we cannot rule out a contribution of p38 toward the enhanced hepatic injury in acetaminophen-treated <italic>Mkp-1<sup>−/−</sup>
</italic> mice.</p>
<p>As in our model, acetaminophen overdose can be fatal in humans, with clinical patients dying from liver failure–related sequelae (Larson et al. <xref ref-type="bibr" rid="bibr31-0192623312447551">2005</xref>; Ostapowicz et al. <xref ref-type="bibr" rid="bibr43-0192623312447551">2002</xref>). Unfortunately, once high doses of acetaminophen are ingested, the efficacy of therapies such as <italic>N</italic>-acetyl cysteine decreases rapidly over time (Rumack et al. <xref ref-type="bibr" rid="bibr49-0192623312447551">1981</xref>), leaving a narrow interval for effective intervention. Our results demonstrate a markedly shortened median survival time in Mkp-1 deficient mice (23 hr vs. 71 hr in wild-type mice, <xref ref-type="fig" rid="fig7-0192623312447551">Fig. 7</xref>). While we did not provide interventional care in this model, we can speculate that a therapy such as <italic>N</italic>-acetyl cysteine might have reduced mortality in the wild-type mice, but not in <italic>Mkp-1<sup>−/−</sup></italic> mice, due to the short interval to death in the Mkp-1 deficient strain. Additionally, since JNK inhibitors have been shown to protect wild-type mice from acetaminophen overdose (Gunawan et al. <xref ref-type="bibr" rid="bibr19-0192623312447551">2006</xref>; Hanawa et al. <xref ref-type="bibr" rid="bibr22-0192623312447551">2008</xref>), we speculate that a JNK-specific inhibitor, when available, would also provide protection to Mkp-1 knockout mice. It is possible that the magnitude of protection from acetaminophen overdose may be different in knockout and wild-type animals, as there may be other factors (e.g., differences in cytochrome p450 induction) that are also influencing the severe phenotype in <italic>Mkp-1</italic> knockout mice.</p>
<p>Since Mkp-1 deficiency correlates with a more severe phenotype in our model, we can speculate that induction of <italic>Mkp-1</italic> may provide protection against an acute hepatotoxic insult. While we did not directly test <italic>Mkp-1</italic> induction as a therapeutic intervention, several treatments can upregulate Mkp-1 expression in hepatocytes, including glucagon (Schliess, Kurz, and Haussinger <xref ref-type="bibr" rid="bibr53-0192623312447551">2000</xref>), S-adenosylmethionine (Tomasi et al. <xref ref-type="bibr" rid="bibr58-0192623312447551">2010</xref>), and high dose dexamethasone (Scheving et al. <xref ref-type="bibr" rid="bibr52-0192623312447551">2007</xref>).  While these agents have a multitude of effects <italic>in vivo</italic>, MkP-1 induction may be one component of their clinically protective effects in related diseases. Additionally, there is precedence for a protective effect of systemic induction of <italic>Mkp-1</italic>, as glutamine has been shown to protect wild-type mice against endotoxemia (Ko et al. <xref ref-type="bibr" rid="bibr29-0192623312447551">2009</xref>) and correlate with reduced signs of acute respiratory distress syndrome (Singleton et al. <xref ref-type="bibr" rid="bibr55-0192623312447551">2005</xref>) in rodent models.</p>
<p>While these results demonstrate that Mkp-1 deficiency is detrimental in acute acetaminophen toxicity, Mkp-1 may not be uniformly hepatoprotective in all diseases. Indeed, Mkp-1 appears to promote the development of hepatic steatosis in a mouse model. Mice lacking both the leptin receptor (db/db) and Mkp-1 were resistant to peroxisome proliferator-activated receptor-γ-mediated hepatic steatosis compared to db/db mice (Flach et al. <xref ref-type="bibr" rid="bibr14-0192623312447551">2011</xref>), and <italic>Mkp-1<sup>−/−</sup></italic> mice are generally resistant to other lipid-mediated diseases such as obesity (Wu et al. <xref ref-type="bibr" rid="bibr63-0192623312447551">2006</xref>).</p>
<p>In our mouse model, Mkp-1 deficiency enhanced hepatotoxicity during acute acetaminophen overdose, correlating with more rapid plasma clearance of acetaminophen, prolonged hepatic JNK activation and decreased total survival compared to wild-type animals. These results suggest that Mkp-1 activation is a novel potential therapeutic target for acute acetaminophen toxicity. Several available compounds are already known to upregulate MkP-1 expression in hepatocytes (Schliess, Kurz, and Haussinger <xref ref-type="bibr" rid="bibr53-0192623312447551">2000</xref>; Tomasi et al. <xref ref-type="bibr" rid="bibr58-0192623312447551">2010</xref>; Scheving et al. <xref ref-type="bibr" rid="bibr52-0192623312447551">2007</xref>). While future studies will be required to verify the therapeutic potential of Mkp-1 induction within the liver, data from this and related studies provide promising indications that MKP-1 may be a novel endogenous hepatoprotective factor during acute hepatotoxicity.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Katherine Heyob for technical assistance with performing the glutathione assays and Molly Augustine for performing the HPLC analysis of plasma acetaminophen.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-0192623312447551">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0192623312447551">
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institute of Allergy and Infectious Disease at the National Institutes of Health [grant numbers R01 AI057798 and AI068956 to Y.L.], the National Center for Complementary &amp; Alternative Medicine at the National Institutes of Health [R01 AT006880 to L.K.R], and the National Center for Research Resources at the National Institutes of Health [T32 RR007073 for stipend support of L.M.W and K01 RR032139 to L.M.W., which is currently supported by the Office of Research Infrastructure Programs as /OD K01 OD010985].</p>
</fn>
</fn-group>
<glossary content-type="abbr">
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="term1-0192623312447551">ALT</term>
<def>
<p>alanine transaminase</p>
</def>
</def-item>
<def-item>
<term id="term2-0192623312447551">DUSP</term>
<def>
<p>dual specificity protein phosphatase</p>
</def>
</def-item>
<def-item>
<term id="term3-0192623312447551">GSH</term>
<def>
<p>reduced glutathione</p>
</def>
</def-item>
<def-item>
<term id="term4-0192623312447551">GSSG</term>
<def>
<p>oxidized glutathione</p>
</def>
</def-item>
<def-item>
<term id="term5-0192623312447551">HPLC</term>
<def>
<p>high-performance liquid chromatography</p>
</def>
</def-item>
<def-item>
<term id="term6-0192623312447551">JNK</term>
<def>
<p>c-Jun N-terminal kinase</p>
</def>
</def-item>
<def-item>
<term id="term7-0192623312447551">MAPK</term>
<def>
<p>mitogen-activated proteins kinases</p>
</def>
</def-item>
<def-item>
<term id="term8-0192623312447551">Mkp-1</term>
<def>
<p>mitogen-activated protein kinase phosphatase-1</p>
</def>
</def-item>
<def-item>
<term id="term9-0192623312447551">NAPQI</term>
<def>
<p>N-acetyl-<italic>p</italic>-benzoquinone imine</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="bibr1-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>J. D.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Lauterburg</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Plasma glutathione and glutathione disulfide in the rat: Regulation and response to oxidative stress</article-title>. <source>J Pharmacol Exp Ther</source> <volume>227</volume>, <fpage>749</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr2-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergmeyer</surname>
<given-names>H. U.</given-names>
</name>
<name>
<surname>Scheibe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wahlefeld</surname>
<given-names>A. W.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>Optimization of methods for aspartate aminotransferase and alanine aminotransferase</article-title>. <source>Clin Chem</source> <volume>24</volume>, <fpage>58</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr3-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Antoniades</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>McPhail</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Bernal</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Vergani</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wendon</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis</article-title>. <source>Liver Int</source> <volume>30</volume>, <fpage>733</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr4-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blazka</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Elwell</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Holladay</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Luster</surname>
<given-names>M. I.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Histopathology of acetaminophen-induced liver changes: Role of interleukin 1 alpha and tumor necrosis factor alpha</article-title>. <source>Toxicol Pathol</source> <volume>24</volume>, <fpage>181</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr5-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogoyevitch</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting</article-title>. <source>Bioessays</source> <volume>28</volume>, <fpage>923</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr6-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourdi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eiras</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Welch</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Pohl</surname>
<given-names>L. R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury</article-title>. <source>Chem Res Toxicol</source> <volume>20</volume>, <fpage>208</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr7-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boutros</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nantel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Emadali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tzimas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Conzen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chevet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Metrakos</surname>
<given-names>P. P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation</article-title>. <source>Am J Transplant</source> <volume>8</volume>, <fpage>2558</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr8-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buckpitt</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Rollins</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>1977</year>). <article-title>Quantitative determination of the glutathione, cysteine, and N-acetyl cysteine conjugates of acetaminophen by high-pressure liquid chromatography</article-title>. <source>Anal Biochem</source> <volume>83</volume>, <fpage>168</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr9-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kokkonen</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages</article-title>. <source>J Immunol</source> <volume>169</volume>, <fpage>6408</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr10-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>103</volume>, <fpage>2274</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr11-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connolly</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Ayo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hackman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bedrosian</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cieza-Rubio</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Henning</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Dorvil-Castro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pachter</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>G</given-names>
</name>
</person-group>. (<year>2011</year>). <article-title>Dendritic cell depletion exacerbates acetaminophen hepatotoxicity</article-title>. <source>Hepatology</source>
<volume>54</volume>, <fpage>959</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr12-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahlin</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>G. T.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S. D.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>81</volume>, <fpage>1327</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr13-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorfman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Carrasco</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gruda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lira</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Bravo</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Disruption of the erp/mkp-1 gene does not affect mouse development: Normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts</article-title>. <source>Oncogene</source> <volume>13</volume>, <fpage>925</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr14-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flach</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27</article-title>. <source>J Biol Chem</source> <volume>286</volume>, <fpage>22195</fpage>–<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr15-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells</article-title>. <source>J Biol Chem</source> <volume>272</volume>, <fpage>16917</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr16-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Srikanth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>95</volume>, <fpage>3014</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr17-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frazier</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wancket</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. A.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nelin</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Cato</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice</article-title>. <source>J Immunol</source> <volume>183</volume>, <fpage>7411</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr18-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Study of P450 function using gene knockout and transgenic mice</article-title>. <source>Arch Biochem Biophys</source> <volume>409</volume>, <fpage>153</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr19-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunawan</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z. X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hanawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gaarde</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N</given-names>
</name>
</person-group>. (<year>2006</year>). <article-title>c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity</article-title>. <source>Gastroenterology</source> <volume>131</volume>, <fpage>165</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr20-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mages</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Servatius</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Howells</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cato</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock</article-title>. <source>J Exp Med</source> <volume>203</volume>, <fpage>15</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr21-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ybanez</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Saberi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Signal transduction pathways involved in drug-induced liver injury</article-title>. <source>Handb Exp Pharmacol</source> <fpage>267</fpage>–<lpage>310</lpage>.</citation>
</ref>
<ref id="bibr22-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saberi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gaarde</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kaplowitz</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury</article-title>. <source>J Biol Chem</source> <volume>283</volume>, <fpage>13565</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr23-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Pollock</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Frew</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mackinnon</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Sethi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure</article-title>. <source>Gut</source> <volume>56</volume>, <fpage>982</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr24-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henry</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Chiamori</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Golub</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Berkman</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1960</year>). <article-title>Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase</article-title>. <source>Am J Clin Pathol</source> <volume>34</volume>, <fpage>381</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr25-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirayama</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Murawaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>The target portion of acetaminophen induced hepatotoxicity in rats: modification by thiol compounds</article-title>. <source>Res Commun Chem Pathol Pharmacol</source> <volume>42</volume>, <fpage>431</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr26-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jollow</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Brodie</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>1973</year>). <article-title>Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo</article-title>. <source>J Pharmacol Exp Ther</source> <volume>187</volume>, <fpage>195</fpage>–<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr27-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jollow</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Thorgeirsson</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen</article-title>. <source>Pharmacology</source> <volume>12</volume>, <fpage>251</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr28-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keyse</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Protein phosphatases and the regulation of mitogen-activated protein kinase signalling</article-title>. <source>Curr Opin Cell Biol</source> <volume>12</volume>, <fpage>186</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr29-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Bang</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>N. I.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1</article-title>. <source>J Immunol</source> <volume>182</volume>, <fpage>7957</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr30-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacour</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Pallardy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Cytokines as potential biomarkers of liver toxicity</article-title>. <source>Cancer Biomark</source> <volume>1</volume>, <fpage>29</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr31-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larson</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Polson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fontana</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Davern</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Lalani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hynan</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Reisch</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Schiodt</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Ostapowicz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shakil</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study</article-title>. <source>Hepatology</source> <volume>42</volume>, <fpage>1364</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr32-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latchoumycandane</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Boelsterli</surname>
<given-names>U. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury</article-title>. <source>Hepatology</source> <volume>45</volume>, <fpage>412</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr33-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Nathans</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells</article-title>. <source>EMBO J</source> <volume>4</volume>, <fpage>3145</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr34-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Bradham</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Czaja</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2002a</year>). <article-title>Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-α</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source> <volume>282</volume>, <fpage>G257</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr35-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Czaja</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2002b</year>). <article-title>NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun</article-title>. <source>Hepatology</source> <volume>35</volume>, <fpage>772</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr36-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gorospe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Holbrook</surname>
<given-names>N.J.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation</article-title>. <source>J Biol Chem</source> <volume>270</volume>, <fpage>8377</fpage>–<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr37-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCloskey</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Kameneva</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Uryash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Billiar</surname>
<given-names>T. R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Tissue hypoxia activates JNK in the liver during hemorrhagic shock</article-title>. <source>Shock</source> <volume>22</volume>, <fpage>380</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr38-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Jollow</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Brodie</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>1973a</year>). <article-title>Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism</article-title>. <source>J Pharmacol Exp Ther</source> <volume>187</volume>, <fpage>185</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr39-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Jollow</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Brodie</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>1973b</year>). <article-title>Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione</article-title>. <source>J Pharmacol Exp Ther</source> <volume>187</volume>, <fpage>211</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr40-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakagawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hikiba</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohmae</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yanai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ichijo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Omata</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation</article-title>. <source>Gastroenterology</source> <volume>135</volume>, <fpage>1311</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr41-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>S. D.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Molecular mechanisms of the hepatotoxicity caused by acetaminophen</article-title>. <source>Semin Liver Dis</source> <volume>10</volume>, <fpage>267</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr42-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nourjah</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Karwoski</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Willy</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States</article-title>. <source>Pharmacoepidemiol Drug Saf</source> <volume>15</volume>, <fpage>398</fpage>–<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr43-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostapowicz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fontana</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Schiodt</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Davern</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>McCashland</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Shakil</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Hynan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Crippin</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Blei</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Reisch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W. M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States</article-title>. <source>Ann Intern Med</source> <volume>137</volume>, <fpage>947</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr44-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Placke</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Ginsberg</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Wyand</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>S. D.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Ultrastructural changes during acute acetaminophen-induced hepatotoxicity in the mouse: A time and dose study</article-title>. <source>Toxicol Pathol</source> <volume>15</volume>, <fpage>431</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr45-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gilfor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Amorino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Valerie</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sealy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hylemon</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes</article-title>. <source>Mol Cell Biol</source> <volume>23</volume>, <fpage>3052</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr46-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raingeaud</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Dickens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ulevitch</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine</article-title>. <source>J Biol Chem</source> <volume>270</volume>, <fpage>7420</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr47-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramachandran</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kakar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Histological patterns in drug-induced liver disease</article-title>. <source>J Clin Pathol</source> <volume>62</volume>, <fpage>481</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr48-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Valentine</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Szczpyka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C. V.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Effects of hepatotoxic doses of acetaminophen and furosemide on tissue concentrations of CoASH and CoASSG in vivo</article-title>. <source>Chem Res Toxicol</source> <volume>13</volume>, <fpage>873</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr49-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rumack</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>I. A.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment</article-title>. <source>Arch Intern Med</source> <volume>141</volume>, <fpage>380</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr50-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saito</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lemasters</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Jaeschke</surname>
<given-names>H</given-names>
</name>
</person-group>. (<year>2010</year>). <article-title>c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity</article-title>. <source>Toxicol Appl Pharmacol</source> <volume>246</volume>, <fpage>8</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr51-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salojin</surname>
<given-names>K. V.</given-names>
</name>
<name>
<surname>Owusu</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Millerchip</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Platt</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Oravecz</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Essential role of MAPK phosphatase-1 in the negative control of innate immune responses</article-title>. <source>J Immunol</source> <volume>176</volume>, <fpage>1899</fpage>–<lpage>907</lpage>.</citation>
</ref>
<ref id="bibr52-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheving</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>W. E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source> <volume>293</volume>, <fpage>G552</fpage>–<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr53-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schliess</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kurz</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Haussinger</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Glucagon-induced expression of the MAP kinase phosphatase MKP-1 in rat hepatocytes</article-title>. <source>Gastroenterology</source> <volume>118</volume>, <fpage>929</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr54-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Gaarde</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Czaja</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance</article-title>. <source>Hepatology</source> <volume>49</volume>, <fpage>87</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr55-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singleton</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Beckey</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Wischmeyer</surname>
<given-names>P. E.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis</article-title>. <source>Shock</source> <volume>24</volume>, <fpage>583</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr56-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Norlin</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Involvement of the PI3K/Akt pathway in estrogen-mediated regulation of human CYP7B1: Identification of CYP7B1 as a novel target for PI3K/Akt and MAPK signalling</article-title>. <source>J Steroid Biochem Mol Biol</source> <volume>112</volume>, <fpage>63</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr57-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>To</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Repetitive microvolumetric sampling and analysis of acetaminophen and its toxicologically relevant metabolites in murine plasma and urine using high performance liquid chromatography</article-title>. <source>J Anal Toxicol</source> <volume>9</volume>, <fpage>217</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr58-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomasi</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Ramani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lopitz-Otsoa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bardag-Gorce</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Iglesias-Ara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pascale</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Mato</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes</article-title>. <source>Hepatology</source> <volume>51</volume>, <fpage>2152</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr59-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Racz</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>McElligott</surname>
<given-names>T. F.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice</article-title>. <source>Am J Pathol</source> <volume>113</volume>, <fpage>321</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr60-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Regulation of innate immune response by MAP kinase phosphatase-1</article-title>. <source>Cell Signal</source> <volume>19</volume>, <fpage>1372</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr61-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kuhlman</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Nelin</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Nicol</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>English</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria</article-title>. <source>J Immunol</source> <volume>178</volume>, <fpage>5312</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr62-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Keeney</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Strobel</surname>
<given-names>H. W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Gene regulation of CYP4F11 in human keratinocyte HaCaT cells</article-title>. <source>Drug Metab Dispos</source> <volume>38</volume>, <fpage>100</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr63-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Neufer</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>G. I.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>A. M</given-names>
</name>
</person-group>. (<year>2006</year>). <article-title>Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity</article-title>. <source>Cell Metab</source> <volume>4</volume>, <fpage>61</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr64-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasunami</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Iwamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kataoka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>C-jun N-terminal kinase modulates 1,25-dihydroxyvitamin D3-induced cytochrome P450 3A4 gene expression</article-title>. <source>Drug Metab. Dispos</source> <volume>32</volume>, <fpage>685</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr65-0192623312447551">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nelin</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Manson</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C. V.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock</article-title>. <source>J Exp Med</source> <volume>203</volume>, <fpage>131</fpage>–<lpage>40</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>